|
Variables
|
GFPT1 expression
|
P value
|
|---|
|
Low (n = 67)
|
High (n = 67)
|
|---|
|
Age, n (%)
| | | |
|
< 60 years
|
29 (43.3%)
|
35 (52.2%)
|
0.299
|
|
≥ 60 years
|
38 (56.7%)
|
32 (47.8%)
|
|
Sex, n (%)
| | | |
|
Male
|
32 (47.8%)
|
40 (59.7%)
|
0.166
|
|
Female
|
35 (52.2%)
|
27 (40.3%)
|
|
Tumor location, n (%)
| | | |
|
Head and neck
|
39 (58.2%)
|
32 (47.8%)
|
0.229
|
|
Body and tail
|
28 (41.8%)
|
35 (52.2%)
|
|
Tumor grade, n (%)
| | | |
|
High and intermediate
|
40 (59.7%)
|
42 (62.7%)
|
0.723
|
|
Low
|
27 (40.3%)
|
25 (37.3%)
|
|
Tumor size, n (%)
| | | |
|
≤ 4.0 cm
|
53 (79.1%)
|
49 (73.1%)
|
0.418
|
|
> 4.0 cm
|
14 (20.9%)
|
18 (26.9%)
| |
|
Nodal metastasis, n (%)
| | | |
|
Absence
|
40 (59.7%)
|
28 (41.8%)
|
0.038*
|
|
Presence
|
27 (40.3%)
|
39 (58.2%)
| |
|
Perineural infiltration, n (%)
| | | |
|
Absence
|
10 (89.1%)
|
13 (77.6%)
|
0.492
|
|
Presence
|
57 (10.9%)
|
54 (22.4%)
|
|
Vessel invasion, n (%)
| | | |
|
Absence
|
51 (76.1%)
|
57 (85.1%)
|
0.190
|
|
Presence
|
16 (23.9%)
|
10 (14.9%)
| |
|
CA199 level, n (%)
| | | |
|
≤ 37 U/ml
|
26 (38.8%)
|
19 (28.4%)
|
0.200
|
|
> 37 U/ml
|
41 (61.2%)
|
48 (71.6%)
| |
- GFPT1 glutamine-fructose-6-phosphate transaminase 1, CA199 carbohydrate antigen 199
- *P value < 0.05
